Search Results 2181-2190 of 13643 for monoclonal antibody
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...
The purpose of this study is to evaluate T cell and antibody immunity in patients with HER2+ breast cancer who will receive trastuzumab with standard ...
* Whether the body makes antibodies against the study drug(s) (which could make the study drug(s) less effective or could lead to side effects). Mayo Clinic ...
* Whether the body makes antibodies against the study drug(s) (which could make the study drug(s) less effective or could lead to side effects). Assessing ...
Mayo Clinic researchers discovered an autoantibody, later called aquaporin-4-immunoglobulin G, that is a specific marker for NMO . Testing for this autoantibody ...
... antibody less than 4 weeks before the first dose of AG-270. A minimum 2-week period between the last treatment with a therapeutic antibody; and the first ...
... antibody (DSA) or increase in preexisting DSA's in presence of elevated dd-cfDNA, and to determine the association of elevated dd-cfDNA with progression of ...
* Whether the body makes antibodies against the study drug(s) (which could make the study drug(s) less effective or could lead to side effects). A Study To ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.